000 | 01212 a2200337 4500 | ||
---|---|---|---|
005 | 20250518001331.0 | ||
264 | 0 | _c20191213 | |
008 | 201912s 0 0 eng d | ||
022 | _a1365-2133 | ||
024 | 7 |
_a10.1111/bjd.17255 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNikkels, A | |
245 | 0 | 0 |
_aShould we provide anti-human papillomavirus vaccination for patients with genital hidradenitis suppurativa? _h[electronic resource] |
260 |
_bThe British journal of dermatology _c01 2019 |
||
300 |
_a233 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 |
_aCarcinoma _xetiology |
650 | 0 | 4 |
_aGenital Diseases, Male _xcomplications |
650 | 0 | 4 |
_aHidradenitis Suppurativa _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPapillomavirus Infections _xetiology |
650 | 0 | 4 |
_aPapillomavirus Vaccines _xadministration & dosage |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSkin Neoplasms _xetiology |
650 | 0 | 4 |
_aSmoking _xadverse effects |
650 | 0 | 4 |
_aVaccination _xmethods |
700 | 1 | _aLebas, E | |
773 | 0 |
_tThe British journal of dermatology _gvol. 180 _gno. 1 _gp. 233 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjd.17255 _zAvailable from publisher's website |
999 |
_c28884738 _d28884738 |